Haemolytic properties of some water-soluble para-sulphonato-calix-[n]- arenes

International Journal of Pharmaceutics

Volumn 273, Issue 1-2, 2004, Pages 57-62

  Da Silva, Eric ^a   Shahgaldian, Patrick ^a,b,c   Coleman, Anthony W ^a  

^a INSTITUT DE BIOLOGIE ET CHIMIE DES PROTÉINES   (France)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY OF APPLIED SCIENCES AND ARTS NORTHWESTERN SWITZERLAND   (Switzerland)

Author keywords

Erythrocyte; Haemolytic; Para Sulphonato calix arene; Water soluble macrocycle

Indexed keywords

4 SULFONATOCALIX[4]ARENE; 4 SULFONATOCALIX[6]ARENE; AMINE; CARBOXYLIC ACID DERIVATIVE; MACROCYCLIC COMPOUND; PHENOL DERIVATIVE; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG SOLUBILITY; ERYTHROCYTE; HEMOLYSIS; HUMAN; HUMAN CELL; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; STOICHIOMETRY;

ARYLSULFONATES; CALIXARENES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; ERYTHROCYTES; HEMOLYSIS; HUMANS; MACROMOLECULAR SUBSTANCES; POLYCYCLIC COMPOUNDS; SOLUBILITY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 1542328826     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2003.12.008     Document Type: Article

References (31)

1. Arena G., Contino A., Gulino F.G., Magri A., Sansone F., Sciotto D., Ungaro R. Complexation of native L-α-amino acids by water soluble calix-[4]-arenes. Tetrahedron Lett. 40:1999;1597-1600.
2. Atwood, J.L., Bridges, R.J., Juneja, R.K., Singh, A.K., 1996. Calixarene Chloride-Channel Blockers. US Patent 5,489,612.
3. Aubert-Foucher, E., Coleman, A.W., Hulmes, D.J.S., 1998. Use of Calix-[n]-Arenes for Treating Fibrotic Diseases. FR 2782007.
4. Bertoux F.C., Freyria A.M., Traeger J. Anticomplement activity or a polyanion: pentosan sulfate. Pathol. Biol. 25:1977;105-108.
5. Bost M., Laine V., Pilard F., Gadelle A., Defaye J., Perly B. The haemolytic properties of chemically modified cyclodextrins. J. Inclusion Phenom. Mol. Recognit. Chem. 29:1997;57-63.
6. Cornforth J.W., D'Arcy Hart P., Nicholls G.A., Rees R.J.W., Stock J.A. Antituberculous effects of certain surface-active polyoxyethylene ethers. Br. J. Pharm. Chem. 10:1955;73-86.
7. Da Silva E., Coleman A.W. Synthesis and complexation properties towards amino acids of mono-substituted p-sulphonato-calix-[n]-arenes. Tetrahedron. 59:2003;7357-7364.
8. Da Silva, E., Memmi, L., Coleman, A.W., Rather, B., Zaworotko, M.J., 2001. Synthesis and Solid-State Structures of Mono-Functionalized para-H-Calix-[6]-Arenes. J.Supramol. Chem. 1, 135-138.
9. Douteau-Guével N., Coleman A.W., Morel J.-P., Morel-Desrosiers N. Complexation of basic amino acids by water-soluble calixarene sulphonates as a study of the possible mechanisms of recognition of calixarene sulphonates by proteins. J. Phys. Org. Chem. 11:1998;693-696.
10. Douteau-Guével N., Coleman A.W., Morel J.-P., Morel-Desrosiers N. Complexation of the basic amino acids lysine and arginine by three sulphonato-calix-[n]-arenes (. n=4, 6 and 8) in water: microcalorimetric determination of the Gibbs energies J. Chem. Soc., Perkin Trans. 2:1999;629-633.
11. Drabkin D.L., Austin J.H. Spectrophotometric studies. II. Preparations from washed blood cells nitric oxide hemoglobin and sulfhemoglobin. J. Biol. Chem. 112:1935;51-65.
12. Gansey M.H.B.G., De Haan A.S., Bos E.S., Verboom W., Reinhoudt D.N. Conjugation, immunoreactivity and immunogenicity of calix-[4]-arenes model study to potential calix-[4]-arene-based Ac3+ chelators. Bioconj. Chem. 10:1999;613-623.
13. Grinberg L.N., Newmark H., Kitrossky N., Rahamim E., Chevion M., Rachmilewitz E.A. Protective effects of tea polyphenols against oxidative damage to red blood cells. Biochem. Pharmacol. 54:1997;973-978.
14. Harris, S.J., 1995. Preparation of calixarene-based compounds having antibacterial, antifungal, anticancer, and anti-HIV activity. PCT Int. Appl. WO 9519974.
15. Huekama K. Recent aspects of pharmaceutical application of cyclodextrins. J. Inclusion Phenom. Macrocyclic Chem. 44:2002;3-7.
16. Hwang, K.M., Qi, Y.M., Liu, S.Y., Lee, T.C., Choy, W., Chen, J., 1995. Antithrombotic Treatment with Calix-[n]-Arene Compounds. US Patent 5,409,959.
17. Kalchenko O.I., Perret F., Coleman A.W. A comparative study of the determination of the stability constants of inclusion complexes of p-sulphonato-calix-[4]-arene with amino acids by RP-HPLC and 1H NMR. J. Chem. Soc., Perkin Trans. 2:2001;258-261.
18. Kalchenko O.I., Da Silva E., Coleman A.W. Determination of the stability constants of inclusion complexes of p-H-37-(2-carboxy-methyloxy)-calix-[6] -arene and p-sulphonato-37-(2-carboxy-methyloxy)-calix-[6]-arene with 15 amino acids by RP-HPLC. J. Inclusion Phenom. Macrocyclic Recognit. Chem. 43:2002;305-310.
19. Leray E., Leroy-Lechat F., Parrot-Lopez H., Duchene D. Reduction of the haemolytic effect in a biologically recognizable β-cyclodextrin. Supramol. Chem. 5:1995;149-151.
20. Lin Q., Park H.S., Hamuro Y., Lee C.S., Hamilton A.D. Protein surface recognition by synthetic agents: design and structural requirements of a family of artificial receptors that bind to cytochrome c. Biopolymers. 47:1998;285-297.
21. Macarak E.J., Kumor K., Paul B. Sulfation and heamolytic activity of cyclodextrin. Biochem. Pharm. 42:1991;1502-1503.
22. Memisoglu E., Bochot A., Oezalp M., Sen M., Duchene D., Hincal A.A. Direct formation of nanospheres from amphiphilic β-cyclodextrin inclusion complexes. Pharm. Res. 20:2003;117-125.
23. Moore G.L., Ledfored M.E., Merydith A. A micromodification of the Drabkin hemoglobin assay for measuring plasma hemoglobin in the range of 5 to 2000 mg/dl. Biochem. Med. 26:1981;167-173.
24. Nagase Y., Hirata M., Arima H., Tajiri S., Nishimoto Y., Hirayama F., Irie T., Uekama K. Protective effect of sulfobutyl ether β-cyclodextrin on DY-9760e-induced haemolysis in vitro. J. Pharm. Sci. 91:2002;2382-2389.
25. Park H.S., Lin Q., Hamilton A.D. Protein surface recognition by synthetic receptors: a route to novel submicromolar inhibitors for β-chymotrypsin. J. Am. Soc. Chem. 121:1999;8-13.
26. Pawlikowska-Pawlega B., Gruszecki W.I., Misiak L.E., Gawron A. The study of the quercetin action on human erythrocyte membranes. Biochem. Pharmacol. 66:2003;605-612.
27. Sansone F., Barboso F., Casnati A., Sciotto D., Ungaro R. A new chiral rigid cone water soluble peptidocalix-[4]-arene and its inclusion complexes with α-amino acids and aromatic ammonium cations. Tetrahedron Lett. 40:1999;4741-4744.
28. Shahgaldian P., Da Silva E., Coleman A.W. A first approach to the study of calixarene solid lipid nanoparticle (SLN) toxicity. J. Inclusion Phenom. Macrocyclic Chem. 46:2003;175-177.
29. Shiotani K., Uehata K., Irie T., Uekama K., Thompson D.O., Stella V.J. Differential effects of sulfate and sulfobutyl ether of b-cyclodextrin on erythrocyte membranes in vitro. Pharm. Res. 12:1995;78-84.
30. Sidorov V., Kotch F.W., Abdrakhmanova G., Mizani R., Fettinger J.C., Davis J.T. Ion channel formation from a calix-[4]-arene amide that binds HCl. J. Am. Chem. Soc. 124:2002;2267-2278.
31. Szetjli, J., 1988. Cyclodextrin Technology. Kluwer Academic Press, Dordrecht.